Hoffmann-La Roche: Arthritis, Rheumatoid trials

The registry lists 219 Arthritis, Rheumatoid studies with Hoffmann-La Roche as lead sponsor. 2 are open to participants now and 139 have results posted.

Phase 1 6Phase 2 22Phase 3 85Phase 4 28No phase 80(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)CompletedNCT00443443
• PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)CompletedNCT00380601Phase 3
• A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.CompletedNCT00365001Phase 1
• A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate TherapyCompletedNCT00316771Phase 2
• A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid ArthritisCompletedNCT00303563Phase 2
• Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNCT00144651Phase 2
• Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3
• Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNCT00144573Not applicable
• Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNCT00144560Not applicable
• Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNCT00144547Phase 3
• Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNCT00144534Phase 3
• Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNCT00144521Phase 3
• Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNCT00144508Phase 3
• A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisCompletedNCT00109408Phase 3
• A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106574Phase 3
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106548Phase 3
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyCompletedNCT00106522Phase 3
• A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid ArthritisCompletedNCT00077870Phase 1/2
• Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisCompletedNCT00074438Phase 2